Partners typically arrive for one and expand into others without re-qualifying a new supplier. The quality systems, documentation standards and supply discipline are shared across all of them.
Over four hundred formulations across oral solids, sterile injectables, capsules, dry syrups and rehydration salts.
Oncology is the clearest measure of whether a manufacturer has the systems it claims to have: contained handling, cytotoxic segregation, lyophilisation and cold chain, on molecules with narrow margins for error.
Neuromuscular blockers, sedatives, analgesics and reversal agents in ampoule and vial presentations.
Supplied for private-label and white-label partnership, or under a partner's own brand. Composition and presentation are agreed against the destination market.
Manufactured under FSSAI Central Licence as a Manufacturer-Exporter of food and health supplements, with laboratory testing at minimum once every six months per product line.
We work backwards from the molecule and the destination market — selecting the dosage form, defining the regulatory route, identifying the facility and preparing the dossier the destination regulator will accept.
DNA testing that helps patients and clinicians confirm genetic variations affecting drug metabolic rates, identify rare genetic disorders, clarify biological relationships and support identity confirmation.
We work on the principle of personalised medicine — that important DNA variations should inform the treatment plan chosen for each individual patient. Tailored treatment based on molecular genetic test results is now a practical possibility rather than a research proposition.
Distribution, contract manufacturing and licensing all reach the same desk. Write to us with the product and the territory, and the first reply will be substantive.